US President Donald Trump announced a deal with AstraZeneca on Friday that he said would lead to significantly lower domestic drug prices in exchange for granting the pharma giant tariff relief.
The agreement, which follows a similar accord announced last month with US giant Pfizer, requires AstraZeneca to charge “Most Favored Nation” pricing — matching the l
Continue Reading on The Guardian Nigeria
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.